Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHFS NASDAQ:DRAD OTCMKTS:NIMU OTCMKTS:NXNN OTCMKTS:VASO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHFSNuwellis$1.08-4.4%$4.79$4.86▼$37.50$6.52M1.55467,323 shs38,696 shsDRADDigirad$2.13$3.58$1.99▼$8.84$10.14M0.18485,592 shs2.25 million shsNIMUNon-Invasive Monitoring Systems$0.06-9.2%$0.04$0.00▼$0.09$9.13M-0.27143,020 shs10,000 shsNXNNNexeon Medsystems$0.00$0.00▼$0.00N/A6.98300 shs200 shsVASOVaso$0.19+7.2%$0.17$0.11▼$0.21$33.08M0.53130,447 shs117,461 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHFSNuwellis0.00%0.00%-0.92%-71.95%+1.90%DRADDigirad0.00%0.00%0.00%0.00%-4.48%NIMUNon-Invasive Monitoring Systems0.00%+47.73%+30.00%+225.00%+1,254.17%NXNNNexeon Medsystems0.00%0.00%0.00%0.00%0.00%VASOVaso0.00%+2.72%+15.55%+2.21%+37.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHFSNuwellis$1.08-4.4%$4.79$4.86▼$37.50$6.52M1.55467,323 shs38,696 shsDRADDigirad$2.13$3.58$1.99▼$8.84$10.14M0.18485,592 shs2.25 million shsNIMUNon-Invasive Monitoring Systems$0.06-9.2%$0.04$0.00▼$0.09$9.13M-0.27143,020 shs10,000 shsNXNNNexeon Medsystems$0.00$0.00▼$0.00N/A6.98300 shs200 shsVASOVaso$0.19+7.2%$0.17$0.11▼$0.21$33.08M0.53130,447 shs117,461 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHFSNuwellis0.00%0.00%-0.92%-71.95%+1.90%DRADDigirad0.00%0.00%0.00%0.00%-4.48%NIMUNon-Invasive Monitoring Systems0.00%+47.73%+30.00%+225.00%+1,254.17%NXNNNexeon Medsystems0.00%0.00%0.00%0.00%0.00%VASOVaso0.00%+2.72%+15.55%+2.21%+37.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHFSNuwellis 0.00N/AN/AN/ADRADDigirad 0.00N/AN/AN/ANIMUNon-Invasive Monitoring Systems 0.00N/AN/AN/ANXNNNexeon Medsystems 0.00N/AN/AN/AVASOVaso 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHFSNuwellis$5.51M1.18N/AN/A$12.79 per share0.08DRADDigirad$114.18M0.09$3.09 per share0.69$10.30 per share0.21NIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/A($0.01) per shareN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AN/AVASOVaso$89.10M0.37$0.04 per share4.61$0.17 per share1.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHFSNuwellis-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/ADRADDigirad-$4.63M-$0.35N/AN/AN/A-5.32%-3.75%-0.85%N/ANIMUNon-Invasive Monitoring Systems-$220KN/AN/AN/AN/AN/AN/A-923.46%N/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AN/AN/AN/AN/AVASOVaso$1.57M$0.0118.82N/AN/A1.76%5.66%1.88%5/13/2026 (Estimated)Latest VASO, DRAD, NIMU, CHFS, and NXNN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/31/2026Q4 2025VASOVasoN/A$0.01N/A$0.01N/A$27.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCHFSNuwellisN/AN/AN/AN/AN/ADRADDigirad$2.20103.29%N/AN/A N/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AVASOVasoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHFSNuwellisN/A6.875.97DRADDigirad0.881.270.91NIMUNon-Invasive Monitoring SystemsN/A0.010.01NXNNNexeon MedsystemsN/AN/AN/AVASOVasoN/A1.591.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHFSNuwellis65.06%DRADDigirad11.38%NIMUNon-Invasive Monitoring Systems0.12%NXNNNexeon MedsystemsN/AVASOVasoN/AInsider OwnershipCompanyInsider OwnershipCHFSNuwellis0.60%DRADDigirad12.49%NIMUNon-Invasive Monitoring Systems28.80%NXNNNexeon Medsystems61.19%VASOVaso43.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHFSNuwellis666.04 millionN/ANot OptionableDRADDigirad6184.76 millionN/ANot OptionableNIMUNon-Invasive Monitoring Systems3154.81 million110.23 millionNot OptionableNXNNNexeon Medsystems60N/AN/ANot OptionableVASOVaso260175.95 million98.80 millionNot OptionableVASO, DRAD, NIMU, CHFS, and NXNN HeadlinesRecent News About These CompaniesVaso (OTCMKTS:VASO) Stock Passes Above Two Hundred Day Moving Average - Here's WhyMay 5 at 3:28 AM | americanbankingnews.comVaso (OTCMKTS:VASO) Share Price Passes Above 200-Day Moving Average - What's Next?April 25, 2026 | americanbankingnews.comNovo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis ...April 21, 2026 | manilatimes.netMCorn In A Cup (Elote En Vaso) RecipeApril 20, 2026 | yahoo.comVaso Corporation (VASO) stock price, news, quote and history - Yahoo FinanceApril 4, 2026 | sg.finance.yahoo.comVaso Stock Declines Post Q4 Earnings Despite Revenue GrowthApril 2, 2026 | zacks.comVaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025March 31, 2026 | markets.businessinsider.comVaso shareholders reelect directors and adopt triennial say-on-payDecember 19, 2025 | tipranks.comVaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCareDecember 17, 2025 | globenewswire.comPositive results for Casgevy but with one patient death from myeloablative busulfan conditioning | ASH 2025December 7, 2025 | managedhealthcareexecutive.comMExa-cel shows complete success in early pediatric trials for sickle cell disease and beta-thalassemiaDecember 7, 2025 | news-medical.netNExa-cel gene therapy may off effective cure for beta-thalassemia and sickle cell disease in children younger than 12December 6, 2025 | medicalxpress.comM‘Extremely encouraging’: Exa-cel benefits kids with sickle cell disease, beta thalassemiaDecember 6, 2025 | healio.comHNanox to acquire VHC IT to accelerate AI deployment in USNovember 21, 2025 | msn.comVASO Food Bank serves veterans during time of high food insecurityNovember 21, 2025 | mvskokemedia.comMVaso Sells Subsidiary VasoHealthcare IT to Nano-XNovember 20, 2025 | tipranks.comNanox Imaging to Acquire VasoHealthcare IT for U.S. AI ExpansionNovember 20, 2025 | msn.comNanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S.November 19, 2025 | caledonianrecord.comCNanox to Boost AI Prowess with VasoHealthcare DealNovember 19, 2025 | mddionline.comMVaso Corporation to sell VasoHealthcare IT to Nano-X ImagingNovember 19, 2025 | msn.comMedia Sentiment Over TimeVASO, DRAD, NIMU, CHFS, and NXNN Company DescriptionsNuwellis NASDAQ:CHFSNuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.Digirad NASDAQ:DRADDigirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.Non-Invasive Monitoring Systems OTCMKTS:NIMU$0.06 -0.01 (-9.23%) As of 11:09 AM EasternNon-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.Nexeon Medsystems OTCMKTS:NXNNNexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.Vaso OTCMKTS:VASO$0.19 +0.01 (+7.18%) As of 03:04 PM EasternVaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
